Cardiotoxic chemotherapy drugs

While antimicrotubular agents such as the taxanes cause cardiotoxicities that include heart block, hypertension, arrythmias, and CHF, recent study of taxane cardiotoxicity has explored if they exacerbate toxicity of other chemotherapy drugs such as anthracyclines or trastuzumab [2,30].

While antimicrotubular agents such as the taxanes cause cardiotoxicities that include heart block, hypertension, arrythmias, and CHF, recent study of taxane cardiotoxicity has explored if they exacerbate toxicity of other chemotherapy drugs such as anthracyclines or trastuzumab [2, 30].

by S Nguyen 2024of cardiotoxicity on chemotherapy regimens including key cancer agents, monitoring parameters, prevention, and the future of chemotherapy. Objectives for

by J Huang 2024 Cited by 49Anthracyclines, such as doxorubicin, represent one group of chemotherapy drugs with the most cardiotoxicity. Despite that anthracyclines are

Some cancer treatments have potential to damage the heart, which is called cardiotoxicity. Certain chemotherapy drugs as well as radiation therapy to the chest

Heart damage that occurs from cancer treatment is called cardiotoxicity. Treatments such as chemotherapy, radiation therapy, and targeted therapy drugs can

Cardiotoxicity is heart damage caused by cancer treatment. It may develop after radiation therapy to the chest or taking certain chemotherapy drugs.

Stanford researchers have developed a test that may help screen for cardiotoxicity in new chemotherapy drugs drug highly cardiotoxic. Three of

While antimicrotubular agents such as the taxanes cause cardiotoxicities that include heart block, hypertension, arrythmias, and CHF, recent study of taxane cardiotoxicity has explored if they exacerbate toxicity of other chemotherapy drugs such as anthracyclines or trastuzumab [2,30].